Assert-IQ vs Viz HCM
AI Verdict
Choose Assert-IQ if…
Choose Assert-IQ if your primary need is long-term, continuous cardiac monitoring for patients with a broad range of suspected heart rhythm disorders, especially when intermittent symptoms make diagnosis challenging. This system provides comprehensive arrhythmia detection over several years, enabling detailed data collection for diagnosis and ongoing management.
View Assert-IQ →Choose Viz HCM if…
Choose Viz HCM if your focus is on the rapid, AI-powered detection of suspected Hypertrophic Cardiomyopathy (HCM) directly from real-time ECG analysis within a hospital or health system. This tool is ideal for quickly identifying patients with this specific condition and immediately coordinating their care across multidisciplinary teams, significantly reducing time to diagnosis and treatment.
View Viz HCM →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Assert-IQ | Viz HCM |
|---|---|---|
| Pricing | Unknown | Subscription-based |
| Deployment | Subcutaneously implanted device with mobile app connectivity | Cloud-based platform, integrated into hospital IT systems (EHR, PACS). |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz HCMViz HCM (Tool B) offers a more comprehensive clinician-focused usability experience with its mobile application providing real-time alerts and seamless integration with major EHR and PACS systems like Epic and Cerner. Assert-IQ (Tool A) provides a patient-facing app and remote programming for clinicians, but its clinician workflow integration details are less explicit than Tool B's.
Clinical Value
Viz HCMWhile Assert-IQ (Tool A) offers long-term, continuous monitoring for various arrhythmias with AI to reduce false positives, Viz HCM (Tool B) stands out as the first and only FDA-cleared AI algorithm for real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM). This targeted approach addresses a significantly underdiagnosed condition, with proven clinical validation and impact on reducing diagnosis time.
Pricing & Value
Viz HCMViz HCM (Tool B) provides greater transparency with its subscription-based pricing model and explicitly highlights the availability of CMS reimbursement through specific CPT codes, offering a clear financial value proposition for healthcare providers. Assert-IQ (Tool A) only states 'enterprise' pricing and requires direct contact for details, lacking this level of transparency.
Enterprise Readiness
Viz HCMViz HCM (Tool B) demonstrates superior enterprise readiness through its cloud-based platform and explicit claims of seamless integration with existing clinical workflows, EHR, and PACS systems, including major vendors like Epic and Cerner. It is also adopted by over 1,400 hospitals. Assert-IQ (Tool A) mentions a hybrid deployment and targets large health systems, but lacks the specific integration details and widespread adoption figures of Tool B.
Innovation
Viz HCMViz HCM (Tool B) represents a more groundbreaking innovation by being the first and only FDA-cleared AI algorithm for real-time ECG analysis to detect a specific, often missed, and serious disease like HCM, and by creating a new regulatory category. While Assert-IQ (Tool A) innovates with its long-lasting Bluetooth ICM and AI for arrhythmia detection, Viz HCM's application of AI for automated disease detection and care coordination for HCM is more transformative.
Support & Docs
Assert-IQAssert-IQ (Tool A) provides comprehensive support, including manuals and guides for both healthcare professionals and patients, 24-hour technical support lines, and personalized one-on-one patient education sessions. While Viz HCM (Tool B) offers a knowledge base and academy, the explicit mention of 24/7 technical support and direct patient assistance for Tool A indicates a more robust and accessible support structure.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Assert-IQ | Viz HCM |
|---|---|---|
| Name | Assert-IQ | Viz HCM |
| Company | Abbott Medical | Viz.ai |
| Description | The Assert-IQu2122 Insertable Cardiac Monitor (ICM) system provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders. | Viz HCM is an FDA-cleared AI tool by Viz.ai that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time. |
| Key Features | Long-term continuous cardiac monitoring (up to 6 years), Advanced arrhythmia detection algorithms, Bluetoothu00ae Low Energy data transmission, Secure cloud-based data platform, Remote monitoring capabilities, Proactive clinician alerts, Patient activator for symptom logging, Minimally invasive insertion | AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection, Real-time disease detection from electrocardiograms, Mobile-based alerts and notifications to multidisciplinary care teams, Automated direction of patients to appropriate care specialists, Reduces time to diagnosis and treatment for HCM, Streamlines cardiac care coordination and clinical workflows, Seamless integration with existing clinical workflows, EHR, and PACS systems, Clinically validated with extensive real-world evidence and publications |
Videos
Demos, reviews, and walkthroughs featuring Assert-IQ and Viz HCM.